Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Bone marrow transplantation [Bone Marrow Transplant] NLMUID: 8702459"" wg kryterium: JN


Tytuł :
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.
Autorzy :
Fløisand Y; Department of Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. .; Centre for Cancer Cell Reprogramming, Department of Molecular Cell Biology, Oslo University Hospital, Oslo, Norway. .
Schroeder MA; Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Chevallier P; CHU de l'Hôtel-Dieu, service d'hématologie clinique, place A. Ricordeau, Nantes, France.
Selleslag D; AZ Sint-Jan Brugge-Oostende, Brugge, Belgium.
Devine S; Center for International Blood and Marrow Transplant Research (CIMBTR) Minneapolis Campus, Minneapolis, MN, USA.
Renteria AS; Hematology Oncology, Cellular and Gene Therapy, ICON Clinical Research Service, New York, NY, USA.
Mohty M; Hematology Department, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, and INSERM UMRs 938, Paris, France.
Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, Lille, France.
Chen C; Millennium Pharmaceuticals Inc, Cambridge, MA, USA.
Parfionovas A; Millennium Pharmaceuticals Inc, Cambridge, MA, USA.
Quadri S; Millennium Pharmaceuticals Inc, Cambridge, MA, USA.
Jansson J; Millennium Pharmaceuticals Inc, Cambridge, MA, USA.
Akbari M; Millennium Pharmaceuticals Inc, Cambridge, MA, USA.
Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun 09. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation.
Autorzy :
Mac S; Department of Pharmacy, City of Hope, Duarte, CA, USA.
Ngo D; Department of Pharmacy, City of Hope, Duarte, CA, USA.
Yang D; Department of Information Sciences, City of Hope, Duarte, CA, USA.
Chen J; Department of Pharmacy, City of Hope, Duarte, CA, USA.
Ali H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Arslan S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Dadwal S; Department of Infectious Diseases, City of Hope, Duarte, CA, USA.
Salhotra A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Cao T; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Karras N; Department of Pediatrics, City of Hope, Duarte, CA, USA.
Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Koller P; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Artz A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Aribi A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Sandhu K; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Stein A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Al Malki MM; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun 09. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation.
Autorzy :
Nampoothiri RV; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Ho L; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
McEwan C; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Pasic I; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Lam W; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Thyagu S; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Gerbitz A; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Mattsson J; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
Kumar R; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun 09. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
Autorzy :
Bonifazi F; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy. .
Defrancesco I; Department of Medical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Olivieri J; Clinica Ematologica, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Barbato F; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Lopedote P; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Dicataldo M; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Sessa M; Hematology Section, Department of Medical Sciences, Azienda Ospedaliero-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
Dan E; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy.
Sinigaglia B; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy.
Zazzeroni L; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy.
Rizzi S; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy.
Tassi C; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy.
Casadei B; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Arpinati M; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto 'L. e A. Seràgnoli', Bologna, Italy.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun 09. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung.
Autorzy :
Kawashima N; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. .
Nishikawa E; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Tsuchisaka A; Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
Hashimoto T; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Okuno Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Genome Medical Center, Nagoya University Hospital, Nagoya, Japan.
Hamada M; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ichikawa D; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Narita A; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Muramatsu H; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nishio N; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Center for Advanced Medicine and Clinical Research, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Kojima S; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Muro Y; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takahashi Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun 09. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score.
Autorzy :
Ait Abdallah N; Unité de Médecine Interne: Maladies Auto-immunes et Pathologie Vasculaire (UF 04), Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France MATHEC, AP-HP, Hôpital Saint-Louis, Paris, France.; Université de Paris, IRSL, Recherche clinique appliquée à l'hématologie, EA, Paris, France.
Wang M; Lady Davis Institute, Montréal, QC, Canada.
Lansiaux P; Unité de Médecine Interne: Maladies Auto-immunes et Pathologie Vasculaire (UF 04), Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France MATHEC, AP-HP, Hôpital Saint-Louis, Paris, France.; Université de Paris, IRSL, Recherche clinique appliquée à l'hématologie, EA, Paris, France.
Puyade M; Service de Médecine Interne, CIC-1402, CHU de Poitiers, Poitiers, France.
Berthier S; Service de médecine interne et immunologie clinique, Hôpital F. Mitterrand, Dijon, France.
Terriou L; Service de médecine interne et immunologie clinique, Hôpital Claude Huriez, CHRU Lille, France.
Charles C; Unité de Médecine Interne: Maladies Auto-immunes et Pathologie Vasculaire (UF 04), Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France MATHEC, AP-HP, Hôpital Saint-Louis, Paris, France.; Université de Paris, IRSL, Recherche clinique appliquée à l'hématologie, EA, Paris, France.
Burt RK; Division of Immunotherapy, Northwestern University, Chicago, IL, USA.
Hudson M; Lady Davis Institute, Montréal, QC, Canada.; McGill University, Montréal, QC, Canada.; Jewish General Hospital, Montréal, QC, Canada.
Farge D; Unité de Médecine Interne: Maladies Auto-immunes et Pathologie Vasculaire (UF 04), Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France MATHEC, AP-HP, Hôpital Saint-Louis, Paris, France. .; Université de Paris, IRSL, Recherche clinique appliquée à l'hématologie, EA, Paris, France. .; Department of Medicine, McGill University, Montreal, QC, Canada. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun 09. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Correction: Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee.
Autorzy :
Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
Badawy SM; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Suelzer EM; Medical College of Wisconsin, Milwaukee, WI, USA.
Murthy HS; Division of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Prasad P; Division of Pediatric Hematology/Oncology, Louisiana State University Health Sciences Center/Children's Hospital of New Orleans, New Orleans, LA, USA.
Eissa H; Department of Pediatrics, University of Colorado School of Medicine, Blood and Marrow Transplant and Cellular Therapy Program, Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA.
Carpenter PA; Fred Hutchinson Cancer Research Center and Department of Pediatrics, University of Washington, Seattle, WA, USA.
Hamadani M; Department of Medicine, BMT and Cellular Therapy Program, Medical College of Wisconsin and Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
Labopin M; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
Schoemans H; Department of Hematology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Tichelli A; Division of Hematology, University Hospital Basel, Basel, Switzerland.
Phelan R; Department of Pediatrics, Division of Hematology and Oncology, and BMT, Medical College of Wisconsin and Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
Hamilton BK; Department of Hematology and Medical Oncology, Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Buchbinder D; Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, CA, USA.
Im A; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Hunter R; Division of Hematology, University of Colorado Anschutz Medical Center, Aurora, CO, USA.
Brazauskas R; Division of Biostatistics, Medical College of Wisconsin and Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
Burns LJ; Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1486.
Typ publikacji :
Published Erratum
Tytuł :
Correction: Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens.
Autorzy :
Versluys AB; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. .
Boelens JJ; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, Memorial Sloan Kettering, New York, NY, USA.
Pronk C; Department of Pediatric Oncology and Hematology, Skane University Hospital, Lund, Sweden.
Lankester A; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
Bordon V; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Ifversen M; Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Jackmann N; Department of Women's and Children's Health, University Children's Hospital, Uppsala, Sweden.
Sundin M; Pediatric Hematology, Immunology and HCT, Astrid Lindgren Children's Hospital, University Hospital; and Division of Pediatrics, CLINTEC, Karolinska Institutet, Stockholm, Sweden.
Vettenranta K; University of Helsinki and Children's Hospital, University of Helsinki, Helsinki, Finland.
Abrahamsson J; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Mellgren K; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1485.
Typ publikacji :
Published Erratum
Tytuł :
The evolving concept of indications for allogeneic hematopoietic cell transplantation during first complete remission of acute myeloid leukemia.
Autorzy :
Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1257-1265. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.
Autorzy :
Bruzzese A; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy. .; Department of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy. .
Assanto GM; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Diverio D; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Quattrocchi L; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Carmini D; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
La Rocca U; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
De Propris MS; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Trisolini SM; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Brescini M; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Galassi G; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Barberi W; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Iori AP; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1482.
Typ publikacji :
Published Erratum
Tytuł :
Association of graft-versus-host-disease with neurologic complications: clinical paradigm and future directions.
Autorzy :
Sheikh MA; Allama Iqbal Medical College/Jinnah Hospital, Lahore, Pakistan.
Im A; Division of Hematology-Oncology, Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Ballen K; Division of Hematology and Oncology, University of Virginia Health System, Charlottesville, VA, USA.
Hashmi SK; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1471-1473. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia.
Autorzy :
Pautas C; Service d'Hématologie et de thérapie cellulaire, Hôpital Henri Mondor, Créteil, France. .
Raffoux E; Hôpital Saint-Louis (AP-HP), EA 3518, Université de Paris, Paris, France.
Lambert J; Service d'Hématologie et Oncologie, Centre Hospitalier de Versailles, Le Chesnay, France.
Legrand O; Service d'hématologie clinique et de thérapie cellulaire, Hôpital Saint-Antoine (AP-HP), Université Paris Pierre et Marie Curie, Paris, France.
Chantepie S; Institut d'Hématologie de Basse-Normandie, Caen, France.
Gastaud L; Service hématologie, Centre Lacassagne, Nice, France.
Marolleau JP; Service hématologie, CHU Amiens, Amiens, France.
Thomas X; Service hématologie, Centre Hospitalier Lyon Sud, Lyon, France.
Turlure P; Service hématologie et de thérapie cellulaire, CHU de Limoges, Limoges, France.
Benner RJ; Global Product Development, Pfizer Inc, Groton, CT, USA.
Vandendries E; Pfizer Inc, Cambridge, MA, USA.
Gogat K; Global Clinical Development, Pfizer Inc, Paris, France.
Dombret H; Hôpital Saint-Louis (AP-HP), EA 3518, Université de Paris, Paris, France.
Castaigne S; Service d'Hématologie et Oncologie, Centre Hospitalier de Versailles, Université de Versailles Saint Quentin, Le Chesnay, France.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1474-1477. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.
Autorzy :
Christopeit M; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Reichard M; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Niederwieser C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Massoud R; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Klyuchnikov E; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Haase N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wolschke C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Heidenreich S; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1478-1481. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.
Autorzy :
Pettengell R; Institute of Medical & Biomedical Education, St George's University of London, London, United Kingdom. .
Uddin R; EBMT Clinical Trials Office, European Society for Blood and Marrow Transplantation, London, United Kingdom.
Boumendil A; Statistics, European Society for Blood and Marrow Transplantation, Paris, France.
Johnson R; Department of Haematology, St James's University Hospital, Leeds, United Kingdom.
Metzner B; University Clinic for Internal Medicine, Oncology and Haematology, Klinikum Oldenburg, Oldenburg, Germany.
Martín A; Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
Romejko-Jarosinska J; Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Institute and Oncology Center, Warsaw, Poland.
Bence-Bruckler I; The University of Ottawa, The Ottawa Hospital, Ottawa, Canada.
Giri P; Haematology, Royal Adelaide Hospital, Adelaide, Southern Australia, Australia.
Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Robinson SP; Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Kimby E; Department of Hematology, Karolinska Institute, Stockholm, Sweden.
Schmitz N; Department of Internal Medicine A, University Hospital Muenster, Muenster, Germany.
Dreger P; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
Goldstone AH; University College London Hospital, London, United Kingdom.
Montoto S; Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1413-1421. Date of Electronic Publication: 2021 Jan 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
Autorzy :
Solano C; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.
Vázquez L; Hematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain.
Giménez E; Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
de la Cámara R; Hematology Department, Hospital de la Princesa, Madrid, Spain.
Albert E; Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Rovira M; Hematology Department, Hospital Clinic Institute of Hematology & Oncology, Barcelona, Spain.
Espigado I; Hematology Department, Hospital Virgen del Rocío, Sevilla, Spain.
Calvo CM; Hematology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
López-Jiménez J; Hematology Department, Hospital Ramón y Cajal, Madrid, Spain.
Suárez-Lledó M; Hematology Department, Hospital Clinic Institute of Hematology & Oncology, Barcelona, Spain.
Chinea A; Hematology Department, Hospital Ramón y Cajal, Madrid, Spain.
Esquirol A; Hematology Department, Hospital Sant Creu i Sant Pau, Barcelona, Spain.
Pérez A; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Bermúdez A; Department of Hematology, Hospital Marques de Valdecilla, Santander, Spain.
Saldaña R; Hematology Department, Hospital Universitario de Jerez, Cádiz, Spain.
Heras I; Hematology Department, Hospital Universitario Morales Meseguer y Centro Regional de Hemodonación, IMIB, Universidad de Murcia, Murcia, Spain.
González-Huerta AJ; Hematology-Stem cell Transplantation Unit, Hospital Universitario Central de Asturias, Oviedo IISPA. IUOPA, Oviedo, Spain.
Torrado T; Hematology Department, Complejo Hospitalario Universitario, Vigo, Spain.
Batlle M; Hematology Department, Hospital Germans Trias i Pujol, Barcelona, Spain.
Jiménez S; Hematology Department, Hospital Universitario Doctor Negrín de Gran Canaria, Las Palmas, Spain.
Vallejo C; Hematology Department Hospital Universitario Donostia-Aránzazu, San Sebastián, Spain.
Barba P; Hematology Department Hospital Universitario Vall de Hebrón, Barcelona, Spain.
Cuesta MÁ; Hematology Department, Hospital Regional Universitario, Málaga, Spain.
Piñana JL; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain, CIBERONC, Instituto Carlos III, Madrid, Spain.
Navarro D; Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain. .; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain. .
Pokaż więcej
Corporate Authors :
Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH)
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1281-1290. Date of Electronic Publication: 2020 Dec 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD.
Autorzy :
Mehta RS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Bassett R; Department of Biostatistics, The University of Texas Cancer Center, Houston, TX, USA.
Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Overman BJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Popat UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Hosing CM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Anderlini P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Jones RB; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Marin D; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Khouri IF; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Oran B; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Ciurea SO; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Kondo K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Couriel DR; Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA.
Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA.
Alousi AM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas Cancer Center, Houston, TX, USA. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1316-1324. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients-evaluation of pre-transplant risk assessments.
Autorzy :
Pahl A; Department of Medicine I, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany. .
Waibel S; Department of Neurology and Neuroscience, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Wehrle A; Department of Sport and Sport Science, University of Freiburg, Freiburg, Germany.
Ihorst G; Clinical Trials Unit, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Gollhofer A; Department of Sport and Sport Science, University of Freiburg, Freiburg, Germany.
Bertz H; Department of Medicine I, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1325-1334. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.
Autorzy :
Bruzzese A; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy. .; Department of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy. .
Assanto GM; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Diverio D; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Quattrocchi L; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Carmini D; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
La Rocca U; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
De Propris MS; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Trisolini SM; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Brescini M; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Galassi G; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Barberi W; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Iori AP; Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1455-1457. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Christmas, wine and Covid-19.
Autorzy :
McCann SR; Haematology Emeritus, University of Dublin Trinity College, Dublin, Ireland. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1227-1228. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.
Autorzy :
Ahmed N; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Li L; Case Western Reserve University, Cleveland, OH, USA.
Rojas P; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Covut F; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Reese-Koc J; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Kolk M; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Malek E; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Metheny L; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
O'Brien T; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Caimi P; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
de Lima M; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Cooper BW; Seidman Cancer Center, University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1458-1461. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Letter
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies